Skip to main content

Comparative efficacy of two combined cloned vaccines against Newcastle disease virus (NDV)

Date: Jun 17, 2019
Authors: Dr. Sasipreeyajan, J.; Khanda, S.; Jongpattanasombat, S.; Keauwprachu, W.; Mansilla, A.; Dias, F.E.

This study comparatively assessed the safety and efficacy of two combined NDV/IB vaccines (HIPRAVIAR® CLON/H120 and a vaccine containing La Sota cloned/IB Ma5) in commercial layers.

This experiment confirmed the efficacy and safety of the use of combined vaccines (HIPRAVIAR® CLON/H120 or La Sota cloned/Ma5) for the control of Newcastle Disease in commercial layers against a controlled challenge with NDV virus genotype VII.

Download this article